Protocol FCR001A2301 - A Randomized, Controlled, Multi-center, Safety and Efficacy Study of FCR001 Cell-Based Therapy Relative to a Tacrolimus and Mycophenolate-Based Regimen in De Novo Living Donor Renal Transplant Recipients, and Safety in FCR001 Donors

Project: Research project

Project Details

Effective start/end date10/2/1910/2/25


  • CTI Clinical Trial and Consulting Services (Protocol FCR001A2301)
  • Regenerex LLC (Protocol FCR001A2301)